Compounded GLP-1s have become more widespread, but are they safe? Some argue that compounding is nothing new, while others believe these drugs are dangerous for patients.
Christina will be part of the panel: "Investor Perspective: What's Hot What's Not". In this session you will hear from a panel of investment leaders from different healthcare industry sectors about the current investment climate. Learn about their strategic priorities and get advice on how startup founders can best succeed in fundraising.
Healthcare AI is developing at a rapid rate, and the industry's attitude on how to best regulate and deploy this technology is evolving every day, according to leaders attending this year's ViVE conference.
BridgeBio Pharma's approval of Beyonttra comes three months after the drug landed FDA approval for cardiomyopathy caused by transthyretin amyloidosis. Our recap of recent regulatory news also spans approvals in cancer, immunology, vaccines, and more.
The distinction between value-based care and value-based payment isn't merely semantic — it represents a crucial fork in the road for healthcare delivery. As AI and other technologies become more prevalent in healthcare, we must ensure they're deployed in service of improving patient care rather than merely optimizing revenue.
For too long, the behavioral health industry has lacked the accountability mechanisms required to deliver on the high quality care that patients deserve. Provider organizations are proving day in, day out that when strong accountability becomes the standard, patients benefit, and the system as a whole grows stronger.
No comments